We have ensured world-class quality in design, equipment and operations in our manufacturing facility. We have access to the state-of-the-art manufacturing sites near Tehran, Iran. This manufacturing units is located in Kaveh industrial zone, Saveh . Our units ensure that we are able to provide best-in-class products to patients across the Iran and emerging markets around. Our manufacturing operations are focused on producing generics and branded generics, in the full range of dosage forms, including tablets, capsules, injectable, pre-filled syringe and freeze dried powder. We have a highly skilled team of regulatory affairs specialists who are well versed with regulatory policies and procedures in Iran. They have a wealth of experience in the timely filing of dossiers as well as handling regulatory queries from both authorities and customers.

Joint venture

By entering in Joint venture, ARANG will take advantage of the strong product portfolio, broad market outreach and experience with the production and commercialization of branded generic medicines. The joint venture will benefit from research and development (R&D), manufacturing quality management, international market promotion and operational capabilities. It will focus on R&D and the production & commercialization of high-quality branded generic medicines, and the broader commercialization of existing medicines through a local and global sales and marketing infrastructure. It will be operated in accordance with international quality standards to advance both companies’ mission of bringing high-quality and affordable medicines to address the medical needs of patients in Iran and worldwide.